Institutional
Patient Square Capital LP
CIK 0001819257
$563.6M
Reported AUM
29
Positions
Q1 2026
Period
2026-05-15
Filed
Portfolio · Q1 2026
Top holdings
| # | Stock | Issuer | Price | Day % | 1Y Gr. | 5Y Gr. | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ROIV | ROIVANT SCIENCES LTD | $33.91 | -1.77% | 199.47% | 240.40% | $226.2M | 40.13% | — | HELD |
| 2 | ARGX | ARGENX SE | $853.82 | -2.15% | 29.50% | 163.60% | $26.8M | 4.76% | — | HELD |
| 3 | INSM | INSMED INC | $98.60 | -2.85% | -10.07% | 248.61% | $25.8M | 4.57% | — | HELD |
| 4 | ONC | BEONE MEDICINES LTD | $316.01 | -1.88% | 5.69% | 2.50% | $23.9M | 4.24% | — | HELD |
| 5 | COGT | COGENT BIOSCIENCES INC | $38.93 | -5.88% | 248.33% | 379.59% | $22.9M | 4.07% | — | HELD |
| 6 | MIRM | MIRUM PHARMACEUTICALS INC | $105.95 | -5.90% | 108.58% | 567.72% | $21.2M | 3.77% | — | HELD |
| 7 | BLTE | BELITE BIO INC | $158.61 | -0.82% | 138.32% | 935.88% | $18.6M | 3.30% | — | HELD |
| 8 | LEGN | LEGEND BIOTECH CORP | $18.55 | -2.62% | -52.19% | -51.55% | $17.9M | 3.18% | — | HELD |
| 9 | NKTR | NEKTAR THERAPEUTICS | $70.67 | -1.09% | 206.86% | -69.66% | $15.1M | 2.68% | — | HELD |
| 10 | DBVT | DBV TECHNOLOGIES S A | $13.50 | -2.24% | 50.00% | 14.02% | $14.5M | 2.57% | — | HELD |
| 11 | PHVS | PHARVARIS N V | $32.62 | -3.72% | 63.35% | 61.81% | $13.9M | 2.47% | — | HELD |
| 12 | ABVX | ABIVAX SA | $124.92 | 0.47% | 72.81% | 1124.93% | $13.5M | 2.40% | — | HELD |
| 13 | XENE | XENON PHARMACEUTICALS INC | $62.67 | -2.37% | 110.46% | 263.68% | $13.2M | 2.34% | — | HELD |
| 14 | CELC | CELCUITY INC | $86.38 | -1.44% | 119.59% | 298.36% | $10.8M | 1.92% | — | HELD |
| 15 | EYPT | EYEPOINT INC | $12.25 | -4.74% | 32.44% | 17.55% | $10.2M | 1.82% | — | HELD |
| 16 | MRK | MERCK & CO INC | $130.22 | 0.33% | 68.33% | 97.86% | $9.6M | 1.71% | — | HELD |
| 17 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | $26.86 | -4.04% | 87.89% | 26.83% | $9.4M | 1.67% | — | HELD |
| 18 | ALLO | ALLOGENE THERAPEUTICS INC | $1.88 | -4.57% | 74.07% | -92.12% | $8.4M | 1.49% | — | HELD |
| 19 | KYMR | KYMERA THERAPEUTICS INC | $103.40 | -3.37% | 140.11% | 66.00% | $8.3M | 1.48% | — | HELD |
| 20 | DNTH | DIANTHUS THERAPEUTICS INC | $106.92 | -5.08% | 447.06% | 10.00% | $7.9M | 1.40% | — | HELD |
| 21 | ELVN | ENLIVEN THERAPEUTICS INC | $54.81 | 1.59% | 192.63% | 186.06% | $7.8M | 1.39% | — | HELD |
| 22 | CATX | PERSPECTIVE THERAPEUTICS INC | $2.91 | -2.68% | -18.75% | -53.28% | $6.8M | 1.20% | — | HELD |
| 23 | DFTX | DEFINIUM THERAPEUTICS INC | $43.52 | -2.18% | 417.89% | 0.83% | $6.3M | 1.11% | — | HELD |
| 24 | HROW | HARROW INC | $38.77 | -0.44% | 24.14% | 265.75% | $5.8M | 1.03% | — | HELD |
| 25 | TARA | PROTARA THERAPEUTICS INC | $3.92 | -2.73% | 28.10% | -53.28% | $5.4M | 0.95% | — | HELD |
| 26 | CTMX | CYTOMX THERAPEUTICS INC. | $3.10 | -5.49% | 33.40% | -38.77% | $5.1M | 0.91% | — | HELD |
| 27 | RCUS | ARCUS BIOSCIENCES INC | $28.19 | -0.21% | 208.41% | -3.15% | $4.2M | 0.75% | — | HELD |
| 28 | ASMB | ASSEMBLY BIOSCIENCES INC | $25.11 | -3.65% | 36.47% | -44.93% | $3.8M | 0.67% | — | HELD |
| 29 | SYRE | SPYRE THERAPEUTICS INC | $98.33 | -3.12% | 524.23% | -44.00% | $50K | 0.01% | — | HELD |
Source: SEC EDGAR · accession 0001819257-26-000003. 13F discloses long positions only — shorts, foreign equities, and options are excluded.